First Horizon Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4K | Sell |
523
-21
| -4% | -$698 | ﹤0.01% | 1476 |
|
|
2025
Q1 | $15.9K | Buy |
544
+40
| +8% | +$1.17K | ﹤0.01% | 1425 |
|
|
2024
Q4 | $16.6K | Sell |
504
-3
| -0.6% | -$99 | ﹤0.01% | 1406 |
|
|
2024
Q3 | $22.5K | Hold |
507
| – | – | ﹤0.01% | 1311 |
|
|
2024
Q2 | $21.9K | Sell |
507
-81
| -14% | -$3.49K | ﹤0.01% | 1239 |
|
|
2024
Q1 | $17.2K | Buy |
588
+162
| +38% | +$4.74K | ﹤0.01% | 1388 |
|
|
2023
Q4 | $9.49K | Buy |
426
+20
| +5% | +$445 | ﹤0.01% | 1613 |
|
|
2023
Q3 | $10K | Buy |
406
+31
| +8% | +$767 | ﹤0.01% | 1508 |
|
|
2023
Q2 | $10.6K | Buy |
375
+54
| +17% | +$1.53K | ﹤0.01% | 1521 |
|
|
2023
Q1 | $7.37K | Sell |
321
-24
| -7% | -$551 | ﹤0.01% | 1676 |
|
|
2022
Q4 | $9.69K | Buy |
345
+27
| +8% | +$758 | ﹤0.01% | 1577 |
|
|
2022
Q3 | $9K | Buy |
318
+42
| +15% | +$1.19K | ﹤0.01% | 1533 |
|
|
2022
Q2 | $6K | Buy |
276
+109
| +65% | +$2.37K | ﹤0.01% | 1742 |
|
|
2022
Q1 | $5K | Buy |
167
+133
| +391% | +$3.98K | ﹤0.01% | 1278 |
|
|
2021
Q4 | $1K | Buy |
34
+22
| +183% | +$647 | ﹤0.01% | 2056 |
|
|
2021
Q3 | $0 | Buy |
+12
| New | – | ﹤0.01% | 2265 |
|
|
2017
Q1 | – | Sell |
-56
| Closed | -$2K | – | 1468 |
|
|
2016
Q4 | $2K | Hold |
56
| – | – | ﹤0.01% | 1308 |
|
|
2016
Q3 | $2K | Sell |
56
-3
| -5% | -$107 | ﹤0.01% | 1299 |
|
|
2016
Q2 | $2K | Hold |
59
| – | – | ﹤0.01% | 1219 |
|
|
2016
Q1 | $2K | Hold |
59
| – | – | ﹤0.01% | 1242 |
|
|
2015
Q4 | $3K | Sell |
59
-30
| -34% | -$1.53K | ﹤0.01% | 1126 |
|
|
2015
Q3 | $6K | Hold |
89
| – | – | ﹤0.01% | 1116 |
|
|
2015
Q2 | $9K | Buy |
89
+3
| +3% | +$303 | ﹤0.01% | 1048 |
|
|
2015
Q1 | $8K | Buy |
+86
| New | +$8K | ﹤0.01% | 1098 |
|